Featured Research

from universities, journals, and other organizations

Treatment of Barrett's esophagus may lower risk of esophageal cancer

Date:
April 4, 2011
Source:
Northwestern Memorial Hospital
Summary:
Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans. New guidelines support use of radiofrequency ablation to remove precancerous cells.

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans. While traditionally managed through watchful waiting, experts at Northwestern Medicine's Center for Esophageal Disease have been among the pioneers of ablation treatment and have long seen the benefits of early treatment.

Related Articles


Frequent heartburn, regurgitation, and trouble swallowing are common symptoms of GERD (gastroesophageal reflux disease), which experts believe is the result of stomach contents washing back into the esophagus leading to the development of Barrett's Esophagus. Repeat exposure to stomach acids can result in damage to the esophagus and cause healthy cells to transform into these precancerous cells. Unfortunately, many patients with Barrett's Esophagus can be asymptomatic.

"The incidence of esophageal cancer is increasing more rapidly than any other type of cancer in the United States and survival rates remain low," said Northwestern Medicine gastroenterologist Srinadh Komanduri, MD. "Barrett's esophagus is a precancerous condition, and while the majority of people who suffer from the disorder will never develop cancer, the risk is present. Early treatment with RFA would likely reduce a patient's chance to develop cancer."

RFA burns away layers of abnormal cells and effectively eliminates the disease in 90-100 percent of patients. Doctors use a flexible tube (endoscopy) inserted into the esophagus to reach the treatment area, which also provides access for taking biopsies or endoscopic resection of suspicious lesions.

Northwestern's Center for Esophageal Disease is the top program in Chicago and has treated more than 130 patients with endoscopic therapy.

"We have seen great results using RFA therapy," said Komanduri who is also an assistant professor of medicine at Northwestern University Feinberg School of Medicine. "It effectively cures Barrett's esophagus in most patients, leads to fewer surgical procedures for the disease, and contributes to lowering the growth rate of esophageal cancer."

The new AGA guidelines recommend RFA treatment for patients with low to high grade dysplasia due to Barrett's esophagus and suggest it as an effective option for high-risk patients without dysplasia. Speak with your physician to determine if you are a candidate.


Story Source:

The above story is based on materials provided by Northwestern Memorial Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern Memorial Hospital. "Treatment of Barrett's esophagus may lower risk of esophageal cancer." ScienceDaily. ScienceDaily, 4 April 2011. <www.sciencedaily.com/releases/2011/04/110404111052.htm>.
Northwestern Memorial Hospital. (2011, April 4). Treatment of Barrett's esophagus may lower risk of esophageal cancer. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2011/04/110404111052.htm
Northwestern Memorial Hospital. "Treatment of Barrett's esophagus may lower risk of esophageal cancer." ScienceDaily. www.sciencedaily.com/releases/2011/04/110404111052.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins